跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
月桂氮酮
首页
药物
月桂氮酮
Approved
Small Molecule
月桂氮酮
Laurocapram
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
18
H
35
NO
CAS 编号
59227-89-3
UNII ID
1F3X9DRV9X
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of laurocapram and cefixime in preparation of medicine for treating MRSA infection
申请人: UNIV JILIN
优先权: 2024
CN
Use of laurocapram in preparation of externally used drug for treating constipation and cosmetic product
申请人: CHEN JIANCAO
优先权: 2005
CN
Absorption enhancer and preparation method and application thereof
申请人: JIAXING JUETUO TECH CO LTD
优先权: 2020
CN
Foot cream and preparation method thereof
申请人: TANGYOU BUTLER (BEIJING) HEALTH MAN CO LTD
优先权: 2017
CN
Penetration-promoting local anesthesia composition and preparation method and application thereof
申请人: SUZHOU GAOMAI PHARMACEUTICAL CO LTD
优先权: 2023
CN
Scar repairing and itching relieving liniment in technical field of scar treatment and preparation process of scar repairing and itching relieving liniment
申请人: DALI BRANCH YUNNAN SHUANGHUAI PRINTING COLD TECH CO LTD
优先权: 2025
CN
Transdermal patch containing diclofenac epolamine and preparation method of transdermal patch
申请人: NANJING HEALTHNICE PHARMACEUTICAL TECH CO LTD
优先权: 2020
CN
Medicine for preventing and treating stiff lump caused by phlebitis and injection
申请人: LI DEMING
优先权: 2004
CN
药物
反馈